What is the best medication to treat a urinary tract infection (UTI) caused by Streptococcus agalactiae (Group B streptococcus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urinary Tract Infection Caused by Streptococcus agalactiae (Group B Streptococcus)

Ampicillin is the first-line treatment for urinary tract infections caused by Streptococcus agalactiae (Group B Streptococcus), with a dosage of 500 mg orally every 6 hours for 5-7 days for uncomplicated infections. 1, 2, 3

First-Line Treatment Options

Penicillins

  • Ampicillin: 500 mg orally every 6 hours for 5-7 days (uncomplicated UTI) 1, 2
    • Multiple studies demonstrate >95% sensitivity of Group B Streptococcus to ampicillin 2, 3, 4
    • For complicated UTIs, treatment should be extended to 10-14 days 5
  • Amoxicillin-clavulanic acid: Alternative first-line option recommended by WHO for GBS UTIs 5

Alternative Treatment Options (for Penicillin-Allergic Patients)

Non-Anaphylactic Penicillin Allergy

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until resolution (for hospitalized patients) 6
  • Nitrofurantoin: 100 mg orally every 6 hours for 5-7 days 5, 7
    • 95.5% sensitivity reported in clinical studies 7

Anaphylactic Penicillin Allergy

  • Vancomycin: 1 g IV every 12 hours (for severe infections requiring hospitalization) 6, 8
    • 95-100% sensitivity reported in multiple studies 3, 7
  • Clindamycin: Only if susceptibility testing confirms sensitivity, as resistance rates up to 77.3% have been reported 3, 4

Important Considerations

Susceptibility Testing

  • Susceptibility testing is essential for penicillin-allergic patients due to increasing resistance to alternative antibiotics 5
  • Resistance patterns to consider:
    • High resistance to tetracycline (81.6%) and co-trimoxazole (68.9%) 7
    • Variable resistance to clindamycin (17.2-77.3%) and erythromycin (21.1%) 3, 4

Special Populations

  • Pregnant women: Penicillin G remains the drug of choice for GBS infections during pregnancy 6
    • 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery
  • Complicated UTIs: Extended treatment duration (10-14 days) is recommended 5

Identifying and Treating Reservoirs

  • Check for potential GBS reservoirs that may cause recurrent infection:
    • Vaginal colonization in women
    • Urethral colonization in men
    • Gastrointestinal tract 2, 9
  • For women with concurrent vaginal colonization, consider topical treatment with chlorhexidine 2% solution 9

Treatment Algorithm

  1. Confirm diagnosis: Positive urine culture with ≥10^5 CFU/ml of Streptococcus agalactiae
  2. Assess patient for penicillin allergy:
    • No allergy → Ampicillin 500 mg orally every 6 hours
    • Non-anaphylactic allergy → Nitrofurantoin 100 mg orally every 6 hours
    • Anaphylactic allergy → Obtain susceptibility testing and use vancomycin if hospitalization required
  3. Determine treatment duration:
    • Uncomplicated UTI: 5-7 days
    • Complicated UTI: 10-14 days
  4. Screen for and treat potential reservoirs to prevent recurrence

The high sensitivity of Group B Streptococcus to penicillins makes ampicillin the optimal choice for treatment, with multiple studies consistently showing >95% susceptibility rates 2, 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.